Emergence Venture Partners

Emergence Venture Partners (EVP) is a global investment and management firm focused exclusively on the healthcare sector, with a primary emphasis on medical technology, aesthetics, dermatology, and digital health. The firm specializes in identifying and scaling high-growth companies through venture capital investments and strategic advisory services. EVP is known for its deep industry expertise and its principals have been instrumental in several landmark healthcare exits, including the early investment and sale of Zeltiq to Allergan and Galderma to EQT. Headquartered in New York with a strong presence in Europe, particularly Paris and Israel, the firm leverages an extensive network to support the international expansion of its portfolio companies. EVP maintains a unique focus on consumer-facing healthcare innovations and medical device disruption.